Korean Journal of Clinical Laboratory Science (대한임상검사과학회지)

Korean Society for Clinical Laboratory Science (대한임상검사과학회)
권호 표지
DOI QR코드

DOI QR Code

Analysis of Coagulation Factor Activity of Normal Adults with APTT Limit Range

APTT에서 경계치에 속한 정상 성인의 혈액응고인자 활성도 분석

  • Kwon, Eui-Hoon (Department of Laboratory Medicine, Samsung Medical Center) ;
  • Koo, Bon-Kyung (Department of Laboratory Medicine, Samsung Medical Center) ;
  • Bang, Sung-Hwan (Department of Laboratory Medicine, Samsung Medical Center) ;
  • Kim, Hee-Jin (Department of Laboratory Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Cho, Young-Kuk (Department of Medical Laboratory Science, Seoyeong University)
  • 권의훈 (삼성서울병원 진단검사의학과) ;
  • 구본경 (삼성서울병원 진단검사의학과) ;
  • 방성환 (삼성서울병원 진단검사의학과) ;
  • 김희진 (성균관대학교 의과대학 삼성서울병원 진단검사의학과) ;
  • 조영국 (서영대학교 임상병리과)
  • Received : 2015.09.10
  • Accepted : 2015.10.07
  • Published : 2015.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

The coagulation factor activity compared two groups of the lower 10% (29.1~30.9 sec) and the upper 10% (38.0~41.9 sec) of the normal reference range of aPTT. The aim of this study was to investigate the influence of sex, age, and ABO blood type on coagulation factor activity. There was significant difference in the activity of the coagulation factor assay based on age. The VIII (p<0.0001) and IX (p=0.0050) in the lower group of samples from those over sixty years of age is higher than from those under sixty. In contrast, XII (p=0.0285) for samples over sixty was lower than for samples under sixty. While in the upper group V (p=0.0219), VIII (p=0.0005), and IX (p=0.0014) for samples from the over sixty group was higher than those under sixty. In the case of activity of coagulation factor between O and non-O blood type, VIII (p<0.001) activity of the non-O blood type was higher than that of the O blood type in the both groups. The XII (p=0.016) activity of non-O blood type was lower than that of O blood type in the upper group. According to the multiple logistic regression analysis, when other variables are under the same conditions between lower and upper groups, there is a strong possibility for the lower group when activity of V (p=0.001), VIII (p<0.001), X (p<0.001) and XII (p<0.001) is increased. Furthermore, there is also a strong possibility of upper group when activity of II (p=0.004) and IX (p=0.012) is increased. However, no significant difference in between sex, age and XI was observed.

aPTT 참고치의 정상범위 내에서 하한 측 10% (29.1~30.9 sec)와 상한 측 10% (38.0~41.9 sec)에 포함된 정상성인의 혈액응고인자 활성도를 분석하여 하한 측과 상한 측간에 혈액응고인자의 종류와 각각의 활성도가 성별, 연령 및 ABO 혈액형 등에 통계학적으로 유의한 차이를 보이는지 알아보고자 하였다. 성별에 따른 혈액응고인자들의 활성도 차이를 분석한 결과 하한 측에서 IX (p=0.0088)만 남성이 여성보다 높았으며, 상한 측에서 IX (p<0.0001)와 X (p=0.0013)은 남성이 여성보다 높았다. 연령군간 혈액응고인자들의 활성도 차이 검정은 하한 측에서 VIII (p<0.0001), IX (p=0.0050)는 60세 이상이 60세 미만보다 높았으며, XII (p=0.0285)는 60세 이상보다 60세 미만이 높았다. 상한 측에서 V (p=0.0219), VIII (p=0.0005), IX (p=0.0014)는 60세 이상이 60세 미만보다 높았다. O형과 non-O형의 혈액형 구분에 의한 혈액응고인자들의 활성도 차이는 VIII (p<0.001)은 양쪽 그룹에서 non-O형이 O형보다 높았으며, XII (p=0.016)는 상한 측에서 non-O형이 O형보다 낮았다.

Keywords

References

  1. CLSI. Defining, establishing and verifying reference intervals in the clinical laboratory; approved guideline, 3rd edition. CLSI document CA28-A3. 2008. Clinical and Laboratory Standards Institute, Wayne, Pennsylbania.
  2. Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L. Cross-laboratory audit of normal reference ranges and assessment of ABO blood group, gender and age on detected levels of plasma coagulation factors. Blood Coagul Fibrinolysis. 2005,16:597-605. https://doi.org/10.1097/01.mbc.0000187250.32630.56
  3. Folsom AR, Conlan MG, Davis CE, Wu KK. Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Ann Epidemiol. 1992,2:481-94. https://doi.org/10.1016/1047-2797(92)90098-B
  4. Fourel V, Gabastou JM, Desroys du Roure F, Ehrhardt N, Robert A. Influence of age, sex and ABO blood group on activated partial thromboplastin time. Haemostasis. 1993,23:321-326.
  5. Gausman JN, Malar RA. Unaccuracy of a "spiked curve" for monitoring UFH therapy. Am J Clin Pathol. 2011,135:870-876. https://doi.org/10.1309/AJCP60ZGXCJKRMJO
  6. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood. 1987,69:1691-1695. https://doi.org/10.1182/blood.V69.6.1691.1691
  7. Jang JH, Seo JY, Bang SH, Park IA, Kim HJ, Kim SH. Establishment of reference intervals for von Willebrand factor antigen and eight coagulation factors in a Korean population following the Clinical and Laboratory Standards Institute guidelines. Blood Coagul Fibrinolysis. 2010,21:251-255. https://doi.org/10.1097/MBC.0b013e3283367931
  8. Jeremic M, Weister O, Gedde-Dahl TW. Factor VIII(AHG) levels in 1016 regular blood donors: The effects of age, sex, and ABO blood groups. Scand J Clin Lab Invest. 1976,36:461-466. https://doi.org/10.3109/00365517609054464
  9. Kim MJ, Lee AN, Song KS, Kim YJ, Shim AS. Influence of Age, Sex and ABO Blood Group on Activated Partial Thromboplastin Time (APTT). Korean J Hemosat Thromb. 1995,2:155-159.
  10. Kitchen S, Jennings I, Woods TAL, Preston FE. Wide variability in the sensitivity of APTT reagents for monitoring of heparin dosage. J Clin Pathol. 1996,49:10-4. https://doi.org/10.1136/jcp.49.1.10
  11. Koo BK, Kwon EH, Ryu KH, Yun JW, Kim HJ. Comparison of Two Methods for Heparin Sensitivity; Activated Partial Thromboplastin Time Assay using in vitro Heparin-spiked Sample and Anti-Xa Assay using in vivo Heparin-treated Sample. Korean J Clin Lab Sci. 2011,43:133-137
  12. Langdell RD, Wagner RH, Brinkhous KM. Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assay procedure. J Lab Clin Med. 1953,41:637-647.
  13. Lowe GD, Rumley A, Woodward M, Morrison CE, Philippou H, Lane DA, et al. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol. 1997,97:775-84. https://doi.org/10.1046/j.1365-2141.1997.1222936.x
  14. Mari D, Coppola R, Provenzano R. Hemostasis factors and aging. Exp Gerontol. 2008,43:66-73. https://doi.org/10.1016/j.exger.2007.06.014
  15. McCallum CJ, Peake IR, Newcombe RG, Bloom AL. Factor VIII levels and blood group antigens. Thromb Haemost. 1983,50:757. https://doi.org/10.1055/s-0038-1665305
  16. McLellan DS, Knight SR, Aronstam A. The relationship between coagulation factor VIII and ABO blood group status. Med Lab Sci. 1988,45:131-134.
  17. Moellera A, Weippert-Kretschmer M, Prinz H, Kretschmer V. Influence of ABO blood groups on primary hemostasis. Transfusion. 2001,41:56-60. https://doi.org/10.1046/j.1537-2995.2001.41010056.x
  18. O'Donnell JS, McKinnon TA, Crawley JT, Lane DA, Laffan MA. Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis. Blood. 2005,106:1988-1991.
  19. Orstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W. Factor VIII and Factor in a twin population: Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet. 1985,37:89-101.
  20. Preston AE, Barr A. The plasma concentration of factor VIII in the normal population. II. The effects of age, sex and blood group. Br J Haematol. 1964,10:238-245. https://doi.org/10.1111/j.1365-2141.1964.tb00698.x
  21. Proctor RR, Rapaport SI. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol. 1961,36:212-219. https://doi.org/10.1093/ajcp/36.3.212
  22. Ross JW, Fraser MD, Moore TD. Analytic clinical laboratory precision: state of the art for thirty-one analysis. Am J Clin Pathol. 1980,74:521-530.
  23. Shetty S, Ghosh K, Mohanty D. Comparison of four commercially available activated partial thromboplastin time reagents using a semi-automated coagulometer. Blood Coagul Fibrinolysis. 2003,14:493-497. https://doi.org/10.1097/00001721-200307000-00011
  24. Souto JC, Almasy L, Muniz-Diaz E, Soria JM, Borrell M, Bayen L, et al. Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol. 2000,20:2024-2028. https://doi.org/10.1161/01.ATV.20.8.2024
  25. Sukhu K, Poovalingam V, Mahomed R, Giangrande PL. Ethnic variation in von Willebrand factor levels can influence the diagnosis of von Willebrand disease. Clin Lab Haematol. 2003,25:247-9. https://doi.org/10.1046/j.1365-2257.2003.00523.x

Cited by

  1. A Comparative Study of Rutin and Rutin Glycoside: Antioxidant Activity, Anti-Inflammatory Effect, Effect on Platelet Aggregation and Blood Coagulation vol.10, pp.11, 2015, https://doi.org/10.3390/antiox10111696